Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
about
Perirenal Edema as a potential hint towards primary hypertension-Preliminary findings in MRI breast cancer stagingEvidence for benefits of angiotensin receptor blockade beyond blood pressure control.Atrial electromechanical delay in patients undergoing heart transplantation.Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.Effects of early and late chronic pressure overload on extracellular matrix remodeling.Therapeutic strategies for diastolic dysfunction: a clinical perspective.Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T₁ mapping.Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertensionC reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.Effects of antihypertensive agents on the left ventricle: clinical implications.Candidate-based proteomics in the search for biomarkers of cardiovascular disease.Do angiotensin II antagonists provide benefits beyond blood pressure reduction?Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population.Hypertensive myocardial fibrosis.Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.Are myocardial fibrosis and diastolic dysfunction reversible in hypertensive heart disease?Dose correction for post-contrast T1 mapping of the heart: the MESA study.Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications.Effects of Losartan and Amlodipine on Left Ventricular Remodeling and Function in Young Stroke-Prone Spontaneously Hypertensive Rats.Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.Mechanisms of cardiac fibrosis in hypertension.Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.Pathological ventricular remodeling: mechanisms: part 1 of 2Biochemical markers of myocardial remodelling in hypertensive heart disease.Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failureRelations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.Atrial fibrillation and renin-angiotensin system.Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.Emerging concepts in cardiac matrix biology.A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease.Update on the association of inflammation and atrial fibrillation.Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients.The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular function.Investigational drugs targeting cardiac fibrosis.The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study.Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.Human interstitial cellular model in therapeutics of heart valve calcification.Use of predictive markers to improve cardiovascular protection.Comparison of Left Ventricular Hypertrophy, Fibrosis and Dysfunction According to Various Disease Mechanisms such as Hypertension, Diabetes Mellitus and Chronic Renal Failure.Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats.
P2860
Q26743419-8816A5F5-0A0D-4E8B-8EA3-6C3559B272FCQ30446535-6A949928-BF86-4515-8F0D-64E59EC0A6C9Q33552987-60BFD510-79B5-40EA-811F-9AD5B7BE93F3Q33791046-F92AB817-C918-47AC-B259-83F7433981ABQ33823159-F4B30503-A823-43EA-B5E6-5DF2D3373A2CQ33928707-D09960E6-15FB-4955-9115-AFE86F135445Q34216754-54F27A81-77F8-4BEA-8DF2-6AE40995D36BQ35584082-28EBB9AC-8C47-4DAF-BA3D-A8C738F1A117Q35584790-1B5AB4C2-4468-4F53-84E8-4AA4020E7A9CQ35631328-13B9FF53-3261-4651-A0CA-C0D8B4553B93Q35990040-45671877-FD96-497C-8F97-8BEBDB460354Q36195282-629358CF-73CF-4C10-938E-484FFFC41A19Q36222011-DCF910DA-815E-4964-B90F-8C92D9A5E280Q36303503-8ADD5724-1487-4AAD-8288-CCF79D740251Q36324110-B30316E7-D6D9-4246-9766-524EEC9C67C7Q36332221-D09BF3EE-8566-4164-998F-80B5BB2D3982Q36540551-8B59CA3D-7DD8-4E04-8CED-2983BE5BB546Q36567763-C54E4B44-5433-4FCA-A6DC-CAE835A5B0EBQ36721831-48BD99E4-229E-4ED1-9038-AB4EC782B4A7Q36815965-4169F222-3FBF-4887-A091-B0B9D0494084Q36873139-041C13E4-EE85-449A-ADEC-98254E5115DCQ37109220-6A5B121E-3355-42D9-826F-08EC9F4B114AQ37241166-FAF441CA-0343-49F6-B586-28EB901B57C2Q37258076-3402AAA3-E6D8-41D4-95E8-B0F71D8D07B1Q37264534-72D532DF-3645-4D85-BD7A-51E6933A0E74Q37312630-0B0FDC8E-96A2-4017-84F2-21C126D57934Q37362745-7A538E10-17AC-48E8-8EAF-ECA5C2E4ABDCQ37623540-0E2AAA4E-6E8A-4AF6-B7C4-0192CBB1A745Q37661389-94FF12A8-1BB9-4222-8FE4-C98076EBC4F4Q37739117-E1F52A83-A95B-4FC1-9EA6-A014E1E29146Q37747604-5150FB2E-9D60-4D34-9BB0-DEEE437E3D97Q37812268-62F3A9FC-ABA1-4A7A-BB9D-B0FABA83405FQ37926767-630CDAA6-E9AF-44FE-BF55-E3238936551BQ38161896-4F9E2403-12E3-404C-93E9-56350340DEE3Q38497180-AE0CC770-4766-40D4-B0A7-ADD4CBC9C238Q39221569-7A285CAC-D6BD-4ED8-BA6E-1FF87F12E15BQ39325703-A1FB928A-7116-430C-844D-89E2DED4FF19Q40199205-2BDC5B83-A306-4213-82E1-74E97AEC033DQ41253251-172C220C-08AF-4E22-957C-E1C0A358D3CCQ41349390-E28DFA2C-6F33-4082-AEE6-9ADCDDE896F3
P2860
Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@en
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@nl
type
label
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@en
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@nl
prefLabel
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@en
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@nl
P2093
P356
P1433
P1476
Usefulness of serum carboxy-te ...... ment in hypertensive patients.
@en
P2093
González A
Martínez Ubago JL
Querejeta R
P304
P356
10.1161/01.CIR.104.3.286
P407
P577
2001-07-01T00:00:00Z